China In-Vitro Diagnostics (IVD) Market (By Segment and Company), Size, Share, Regulations, Reimbursement, Major Deals, Trends & Recent Developments - Forecast to 2028

China In-Vitro Diagnostics (IVD) Market (By Segment and Company), Size, Share, Regulations, Reimbursement, Major Deals, Trends & Recent Developments - Forecast to 2028

China In-Vitro Diagnostics (IVD) market is predicted to exceed US$ 25 Billion by 2028. China is a large and fast-growing in vitro diagnostics (IVD) market - in fact, the largest in vitro diagnostics market in the Asia-Pacific region, and only second to the United States in terms of value. Due to the upsurge of the geriatric population and the high burden of chronic and infectious diseases, like diabetes, cancer, and COVID-19, the China IVD market is slated to show significant growth, as these chronic disorders can be diagnosed and monitored using in-vitro diagnostics (IVD) products. Moreover, The State Council issued a guideline to implement the country's Healthy China initiative to diminish the incidence of disability among elderly people aged between 65 and 74 years by offering medical and health services. Such initiatives by the government are expected to boost market growth during the forecast period. However, a lack of proper reimbursement and stringent regulatory framework restricts the market’s growth.

China In Vitro Diagnostics (IVD) Market – Recent Developments

• In April 2023, Oxford Nanopore Technologies plc, and bioMérieux SA teamed up to improve health outcomes globally by exploring selected opportunities to bring nanopore sequencing to the infectious disease diagnostics market.
• In December 2022, bioMérieux announced the CE-marking of VIDAS KUBE, the next generation automated immunoassay system for the VIDAS range.
• In July 2022, DiaCarta Inc., a molecular diagnostics company announced that the company has received CE-IVD Mark for its newly developed QuantiVirus SARS-CoV-2 & Flu A/B test.
• In February 2022, Sysmex Corporation formed a capital and business tie-up with KAINOS Laboratories, Inc. with a view toward strengthening capabilities to develop and produce diagnostic reagents in the immunochemistry field.

By Segment China IVD Market and Forecast – Key Takeaway

• Immunoassays accounted for lion’s share of the total China IVD market, and is likely to maintain its dominant position over the forecast period as well.
• Clinical Chemistry holds the 2nd position in the China IVD market, but its share is likely to continually decline over the forecast period.
• Molecular Testing is the fastest growing segment of the China IVD market, driven by increasing demand for polymerase chain reaction (PCR) products in China.
• China SMBG market is dominated by foreign IVD companies such as Roche.
• SMBG and Hematology segments are competing closely with each other to grab maximum share of the pie.

China IVD Market Company Analysis

• In the China IVD market, Roche Diagnostics is the leader with majority share, followed by Danaher Corporation, Shanghai Kehua Bio-Engineering Co. Ltd. and Mindray Medical International Limited.
• Sysmex Corporation, Abbott Laboratories, and Thermo Fisher Scientific Inc. are the other top players in the China IVD market.
• Sysmex is focusing on Tier 2 and 3 hospitals in China, as they will play a crucial role in providing more advanced treatment, training future generations, and raising the level of regional medical care.
• In the diagnostics business, Abbott will focus on driving sales growth from its Alinity suite of diagnostics instruments and its portfolio of rapid diagnostic testing system.
• In April 2023, bioMérieux submitted a 510(k) premarket notification to the U.S. FDA for the VITEK REVEAL, formerly known as SPECIFIC REVEAL Rapid AST System.

iGATE RESEARCH report titled “China In-Vitro Diagnostics (IVD) Market (By Segment and Company), Size, Share, Regulations, Reimbursement, Major Deals, Trends & Recent Developments - Forecast to 2028” provides a comprehensive analysis of the China In-Vitro Diagnostics (IVD) Market.

This 247 Page report with 39 Figures and 5 Tables has been analyzed from 12 View Points:

1) China IVD Market and Forecast (2010 - 2028)
2) China IVD Market Share and Forecast (2010 - 2028)
3) China IVD Market & Forecast - By Segment (2010 - 2028)
4) Development Environment and Regulatory Status in China IVD market
5) China IVD Market - Key Players Sales Analysis (2015 - 2028)
6) Registration for In Vitro Diagnostic Reagents in China
7) Regulatory History/Status/Trends in China IVD Market
8) Reimbursement of IVD Products in China
9) Profiles of Select Private Clinical Labs and Diagnostic Services Companies
10) IVD Market - Major Deals
11) IVD Market - Recent Developments
12) China IVD Industry Drivers & Challenges

China IVD Market - By Application Segment

1. Clinical Chemistry
2. Immunoassays
3. Hematology
4. Coagulation
5. Microbiology
6. Molecular Testing
7. Self-Monitoring of Blood Glucose (SMBG)
8. Point of Care Testing (POCT)

China IVD Market - Key Players Sales Analysis

1. Roche Diagnostics
2. Abbott Laboratories
3. Sysmex Corporation
4. Mindray Medical International Limited
5. Shanghai Kehua Bio-Engineering Co. Ltd.
6. bioMérieux SA
7. Bio-Rad Laboratories, Inc
8. Danaher Corporation
9. Thermo Fisher Scientific Inc.
10. Others

Profiles of Private Clinical Labs and Diagnostic Services Companies in China

• Dian Diagnostics Group Co. Ltd. (Formerly Zhejiang Di’an Diagnostics Technology Co., Ltd.)
• ADICON Clinical Laboratories
• Guangzhou Kingmed Diagnostics Center Co. Ltd.
• Kindstar Global
• BGI-Shenzhen
• OriGene Technologies

Data Source

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies:

Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies:

Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.